Reach Us +44-1904-929220
Molecular Characterization And Current Treatment Strategy Of Glioblastoma Multiforme | 3663

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Molecular characterization and current treatment strategy of glioblastoma multiforme

2nd World Congress on Biomarkers & Clinical Research

Xiang Zhang, Wei Zhang, Weidong Cao, Gang Cheng, Yongqiang Zhang, Bo-lin Liu and Jin-xiang Cheng

ScientificTracks Abstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.2

Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumor in human and is classifi ed by the WHO in the group of diff usely infi ltrative astrocytomas, representing the most malignant subtype of them. Th e aberrant genetic events and signaling pathways have been clearly demonstrated. Th ey are cellular, highly anaplastic, and morphologically highly heterogeneous tumors. Understanding the genetic alterations, specifi c molecular biomarkers and proliferative pathways might promote therapeutic development for the management of GBM. In this article, we review the molecular characterization of GBM cells and current treatment strategy, including gross or near-total resection of the tumor, followed by radiotherapy and concurrent chemotherapy, stereotactic brachytherapy and new targeted therapies. Th e multimodal approaches for the treatment of GBM improve the prognosis.
Relevant Topics